19 results on '"Echizen, Hirotoshi"'
Search Results
2. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients
3. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients
4. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6β-hydroxycortisol
5. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children
6. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone
7. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes
8. CYP2C9 and Oral Anticoagulation Therapy with Acenocoumarol and Warfarin: Similarities yet Differences*.
9. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients*.
10. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients*.
11. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6β-hydroxycortisol*.
12. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children*.
13. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone*.
14. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*.
15. Famotidine-associated central nervous system reactions and plasma and cerebrospinal drug concentrations in neurosurgical patients with renal failure.
16. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
17. Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects.
18. Disposition kinetics and dynamics of nicainoprol, a new antiarrhythmic agent, in humans.
19. Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.